Estonia vs Uzbekistan: Cause of death, by non-communicable diseases, female
Estonia
85.2%
in 2021
Uzbekistan
85.0%
in 2021
Estonia rank
15th
Uzbekistan rank
17th
Cause of death, by non-communicable diseases, female over time
- Estonia
- Uzbekistan
How they compare
Estonia currently reports 85.2% against 85.0% in Uzbekistan, a difference of 0.2%.
Across all 6 years both countries report, Estonia has been ahead every year.
Estonia ranks 15th and Uzbekistan ranks 17th of 185 countries.
Estonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Estonia | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.5% | 81.7% | 11.8% | Estonia |
| 2010s | 95.3% | 89.8% | 5.4% | Estonia |
| 2020s | 89.0% | 85.6% | 3.4% | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Estonia or Uzbekistan?
- Estonia, at 85.2% against 85.0% in Uzbekistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Estonia and Uzbekistan?
- 0.2%, with Estonia ahead.
- How many years of comparable data are there for Estonia and Uzbekistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Estonia and Uzbekistan rank globally for cause of death, by non-communicable diseases, female?
- Estonia ranks 15th and Uzbekistan ranks 17th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.